Analystreport

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $175.00 price

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com